• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

格雷夫斯病的诊断与治疗,特别强调核医学中的适当技术。知识概况。

Diagnosis and treatment of Graves' disease with particular emphasis on appropriate techniques in nuclear medicine. General state of knowledge.

作者信息

Prasek Karolina, Płazińska Maria Teresa, Królicki Leszek

机构信息

Department of Nuclear Medicine, Warsaw Medical University, Poland.

出版信息

Nucl Med Rev Cent East Eur. 2015;18(2):110-6. doi: 10.5603/NMR.2015.0026.

DOI:10.5603/NMR.2015.0026
PMID:26315874
Abstract

Graves' disease is an autoimmune disease. It accounts for 50-80% of cases of hyperthyroidism. Antibodies against the TSH receptor (TRAb) are responsible for hyperthyroidism (TRAB). The key role in monitoring and diagnosis of Graves' disease plays the level of hormones of free thyroxine and triiodothyronine. Helpful is an ultrasound of the thyroid scintigraphy which due to its functional character is both a valuable addition to morphological studies as well as plays an important role in the diagnosis and therapy in patients with Graves' disease. There is no perfect treatment for Graves' disease. The reason for this is the lack of therapy directed against primary pathogenic mechanisms. Currently available treatments need to be thoroughly discussed during the first visit as the patient's understanding of the choice of a treatment constitutes a vital role in the success of therapy. Graves' disease treatment is based on three types of therapies that have been carried out for decades including: pharmacological treatment anti-thyroid drugs, I131 therapy and radical treatment - thyroidectomy. The purpose of the treatment is to control symptoms and patient to return to euthyreosis. Treatment of Graves' disease is of great importance because if left untreated, it can lead to long-term harmful effects on the heart, bone and mental well-being of patients.

摘要

格雷夫斯病是一种自身免疫性疾病。它占甲状腺功能亢进病例的50 - 80%。针对促甲状腺激素受体(TRAb)的抗体导致甲状腺功能亢进(TRAB)。游离甲状腺素和三碘甲状腺原氨酸激素水平在格雷夫斯病的监测和诊断中起关键作用。甲状腺闪烁扫描超声检查很有帮助,由于其功能特性,它既是形态学研究的重要补充,在格雷夫斯病患者的诊断和治疗中也发挥着重要作用。目前尚无针对格雷夫斯病的完美治疗方法。原因是缺乏针对主要致病机制的治疗。由于患者对治疗选择的理解对治疗成功至关重要,因此在首次就诊时需要充分讨论目前可用的治疗方法。格雷夫斯病的治疗基于已经实施了数十年的三种治疗方法,包括:药物治疗(抗甲状腺药物)、I131治疗和根治性治疗——甲状腺切除术。治疗的目的是控制症状并使患者恢复甲状腺功能正常。格雷夫斯病的治疗非常重要,因为如果不治疗,它会对患者的心脏、骨骼和心理健康产生长期有害影响。

相似文献

1
Diagnosis and treatment of Graves' disease with particular emphasis on appropriate techniques in nuclear medicine. General state of knowledge.格雷夫斯病的诊断与治疗,特别强调核医学中的适当技术。知识概况。
Nucl Med Rev Cent East Eur. 2015;18(2):110-6. doi: 10.5603/NMR.2015.0026.
2
Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO).第二代抗促甲状腺素受体抗体(TRAb)放射免疫分析法在自身免疫性甲状腺疾病中的评估。与第一代抗促甲状腺素受体抗体及抗甲状腺过氧化物酶抗体(AbTPO)的比较。
Q J Nucl Med. 2001 Mar;45(1):115-9.
3
[Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].[西班牙格雷夫斯病诊断与治疗标准的演变。1987年和1995年两项调查结果的比较]
Med Clin (Barc). 1998 Sep 5;111(6):205-10.
4
Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.停用抗甲状腺药物治疗一个月后进行促甲状腺素和促甲状腺素受体抗体检测,以此作为格雷夫斯病复发的预测指标。
Thyroid. 2005 Sep;15(9):1047-54. doi: 10.1089/thy.2005.15.1047.
5
Hashimoto's thyroiditis following Graves' disease.格雷夫斯病后发生的桥本甲状腺炎。
Acta Med Indones. 2010 Jan;42(1):31-5.
6
Treatment outcome of Graves' disease in Thai children.泰国儿童Graves病的治疗结果
J Med Assoc Thai. 2007 Sep;90(9):1815-20.
7
TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.促甲状腺激素受体自身抗体——格雷夫斯病与毒性多结节性甲状腺肿所致甲状腺功能亢进的鉴别
Exp Clin Endocrinol Diabetes. 2004 Apr;112(4):171-4. doi: 10.1055/s-2004-817930.
8
Pregnancy after definitive treatment for Graves' disease--does treatment choice influence outcome?Graves病确诊治疗后的妊娠——治疗选择会影响结局吗?
Aust N Z J Obstet Gynaecol. 2014 Aug;54(4):317-21. doi: 10.1111/ajo.12196. Epub 2014 Feb 27.
9
Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.采用高浓度聚乙二醇的灵敏促甲状腺素抗体检测法诊断格雷夫斯病。
Clin Exp Pharmacol Physiol. 2004 May-Jun;31(5-6):314-9. doi: 10.1111/j.1440-1681.2004.03991.x.
10
Therapy insight: management of Graves' disease during pregnancy.治疗洞察:妊娠期格雷夫斯病的管理
Nat Clin Pract Endocrinol Metab. 2007 Jun;3(6):470-8. doi: 10.1038/ncpendmet0508.

引用本文的文献

1
Predictive factors influencing hypothyroidism following the radioactive iodine treatment of Graves' disease in different periods.不同时期放射性碘治疗Graves病后影响甲状腺功能减退的预测因素。
Sci Rep. 2024 Dec 28;14(1):31148. doi: 10.1038/s41598-024-82521-5.
2
Type 2 Autoimmune Polyglandular Syndrome Presenting with Hyperpigmentation and Amenorrhea.表现为色素沉着和闭经的2型自身免疫性多腺体综合征。
Cureus. 2020 Apr 21;12(4):e7772. doi: 10.7759/cureus.7772.
3
Exosomes as Mediators of Cell-to-Cell Communication in Thyroid Disease.
外泌体作为甲状腺疾病中细胞间通讯的介质
Int J Endocrinol. 2020 Apr 28;2020:4378345. doi: 10.1155/2020/4378345. eCollection 2020.
4
Mechanism of Action and Interactions between Thyroid Peroxidase and Lipoxygenase Inhibitors Derived from Plant Sources.甲状腺过氧化物酶与植物来源的脂氧合酶抑制剂的作用机制及相互作用。
Biomolecules. 2019 Oct 29;9(11):663. doi: 10.3390/biom9110663.
5
[Iodine 131 joint radio frequency ablation treatment for child with hyperthyroidism goiter: one case report].碘131联合射频消融治疗儿童甲状腺功能亢进性甲状腺肿1例报告
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2017 Jan 25;46(1):89-91. doi: 10.3785/j.issn.1008-9292.2017.02.13.